Product Details
2025-2026 Afluria® 5 ml multi-dose vial, FLU-106, 10 Doses/Vial
Manufacturer: SEQIRUS, INC.
MFG#: FLU2025001
PID: 638975
1/VL
$294.38
Out of StockAdditional Information
| Product Name | 2025–2026 Afluria® 5 mL Multi-Dose Vial, Flu-106 |
| Vaccine Type | Inactivated influenza vaccine (egg-based) |
| Strains Covered | WHO-recommended influenza A(H1N1), A(H3N2), and B lineages for 2025–2026 |
| Volume | 5 mL per vial |
| Doses per Vial | 10 doses (0.5 mL each) |
| Route of Administration | Intramuscular (IM) |
| Preservatives | Contains thimerosal (for multi-dose vial sterility) |
| Common Side Effects | Injection site pain, swelling, fatigue, headache, myalgia |
| Serious Side Effects | Rare: anaphylaxis, Guillain-Barré syndrome |
| Contraindications | Severe allergic reaction to vaccine, egg protein, or any component |
| Storage Conditions | 2°C to 8°C (36°F to 46°F); do not freeze |
| Shelf Life After Opening | Use within 28 days after first vial puncture |
| Packaging | Carton with one 5 mL multi-dose vial labeled Flu-106 |
| Approval Status | FDA-approved for seasonal influenza vaccination |
| Indication | Prevention of influenza (A and B strains) for ages =6 months |
Description
Afluria® 2025-2026 (5 mL Multi-Dose Vial, Flu-106) is an inactivated influenza vaccine indicated for active immunization against influenza virus subtypes A and B. It is formulated for the 2025–2026 flu season, containing antigens corresponding to the strains most likely to circulate. The vaccine is developed using egg-based manufacturing and is approved for individuals aged 6 months and older.
Each multi-dose vial contains 5 mL of suspension, delivering ten 0.5 mL doses. The vaccine is administered intramuscularly, typically into the deltoid muscle of adults or the anterolateral thigh for younger children. Afluria® does not contain any live virus, and it cannot cause influenza illness. Preservatives, including thimerosal, are present to maintain sterility of the multi-dose format.
Common side effects include injection site pain, redness, swelling, muscle aches, fatigue, and headache. Serious adverse events are rare but may include allergic reactions or Guillain-Barré syndrome. Caution is advised in individuals with a history of severe allergic reaction to previous influenza vaccines, egg proteins, or other vaccine components.
Frequently Asked Questions (FAQs)
The cost of 2025-2026 Afluria® 5 ml multi-dose vial, FLU-106, 10 Doses/Vial is $$294.38
2025-2026 Afluria® 5 ml multi-dose vial, FLU-106, 10 Doses/Vial is manufactured by SEQIRUS, INC..
You can purchase 2025-2026 Afluria® 5 ml multi-dose vial, FLU-106, 10 Doses/Vial on our website at https://supplies.pipelinemedical.com/product/detail/2025-2026-afluria®-5-ml-multi-dose-vial-flu-106-10-doses-vial-638985